Browse categories and answer follow-up questions to refine your symptom profile.
Approach to the Critical Patient
Immediate priorities
Time critical stabilization
Escalate to resuscitation bay for hypotension or altered mental status
Sepsis protocol if suspected systemic infection
If airway compromise, then airway management
Post intubation sedation and analgesia to target comfort
If shock, then IV crystalloid bolus 20-30 mL/kg
Norepinephrine infusion if MAP < 65 mmHg after fluids
Pain control plan prior to joint procedures
If severe pain, then IV opioid titration with monitoring
Early diagnostic and source control plan
Arthrocentesis priority before antibiotics when feasible
If unstable or high sepsis risk, then antibiotics not delayed for aspiration
Blood cultures x2 before antibiotics if feasible
If antibiotics already given, then still obtain cultures
Early orthopedic consultation for suspected septic joint
Immediate consultation for hip, shoulder, prosthetic joint, or rapid clinical decline
Key concepts
Septic arthritis as joint space infection with rapid cartilage destruction
Irreversible damage possible within 24-48 hours without drainage and antibiotics
Diagnosis anchored on synovial fluid studies
Culture as definitive test
Drainage as essential therapy
Repeated aspiration vs arthroscopic or open washout based on joint and response
Red flags and escalation
High risk features
Hemodynamic instability
Lactate elevation or rising trend
Hip involvement
Limited range of motion with inability to bear weight
Immunocompromised state
Neutropenia or high dose steroids or transplant
Prosthetic joint
Early postoperative infection concern
Overlying cellulitis with systemic signs
Necrotizing infection concern if pain out of proportion
History
Symptom pattern
Presentation pattern
Acute monoarticular pain
Rapid onset over hours to days
Swelling and warmth
Functional limitation
Fever or chills
Absence of fever does not exclude
Inability to bear weight
Hip and knee high concern
Time course and triggers
Symptom onset time
Progression speed
Recent trauma or joint procedure
Injection or arthroscopy
Recent infection source
Skin and soft tissue infection
Urinary tract infection
Pneumonia
Exposure risks
Recent sexual exposure
Gonococcal arthritis risk
Tick exposure
Lyme arthritis risk
Animal bite or scratch
Pasteurella risk
Travel or freshwater exposure
Unusual pathogens risk
Risk factors
Host risk factors
Age over 65 years
Higher bacteremia risk
Diabetes mellitus
Higher infection risk
Rheumatoid arthritis or inflammatory arthritis
Baseline effusions confounding diagnosis
Chronic kidney disease or dialysis
MRSA risk
Immunosuppression
Atypical organisms risk
HIV
Disseminated infection risk
Joint specific risk factors
Prosthetic joint
Chronic pain baseline confounding
Crystal arthropathy history
Gout and pseudogout can coexist with infection
Prior septic arthritis
Recurrence risk
Injection drug use
MRSA and gram negative risk
Physical Exam
Joint focused exam
Local findings
Effusion
Ballotment where applicable
Warmth and erythema
Overlying cellulitis extent
Tenderness
Pain with minimal passive motion
Range of motion limitation
Pain greatest with passive ROM
Joint specific considerations
Hip
Pain with internal rotation
Shoulder
Limited abduction and external rotation
Wrist and hand
Tenosynovitis signs for disseminated gonococcal infection
Systemic exam
Vital signs and perfusion
Fever
Afebrile presentations in elderly and immunocompromised
Tachycardia
Sepsis trigger
Hypotension
Shock trigger
Source exam
Skin
Abscess or cellulitis
Cardiac
Murmur suggesting endocarditis
Genitourinary
Urethral discharge or cervicitis
Spine
Back pain suggesting epidural abscess or osteomyelitis
PITFALLS
Diagnostic pitfalls
Normal temperature
Septic arthritis still possible
Crystal identification in synovial fluid
Does not exclude concomitant infection
Partial antibiotic exposure
Lower culture yield and blunted synovial WBC
Immunosuppression
Lower synovial WBC despite infection
Differential Diagnosis
Life threatening and limb threatening
High risk differentials
Septic arthritis
ICD-10 M00.9
Necrotizing soft tissue infection
Rapid progression and pain out of proportion
Septic bursitis
Olecranon or prepatellar swelling
Osteomyelitis contiguous to joint
Persistent pain despite aspiration
Endocarditis with septic emboli
Bacteremia with joint symptoms
Mimics
Crystal arthritis
Gout ICD-10 M10.- and CPPD ICD-10 M11.-
Hemarthrosis
Anticoagulation or bleeding disorder
Reactive arthritis
Post GI or GU infection
Inflammatory arthritis flare
Rheumatoid arthritis ICD-10 M06.9
Lyme arthritis
Large joint effusion with subacute course
Gonococcal arthritis
Migratory polyarthralgia or tenosynovitis
Cellulitis or abscess near joint
Soft tissue source without true intraarticular infection
Coding and terminology
Standard terms
Septic arthritis
SNOMED CT concept for septic arthritis of joint
Pyogenic arthritis
ICD-10 M00.- categories by organism where known
Prosthetic joint infection
ICD-10 T84.5- infection and inflammatory reaction due to internal joint prosthesis
Laboratory Tests
Blood tests
Infection and inflammation labs
Complete blood count for leukocytosis and baseline
Normal WBC does not exclude
C reactive protein for inflammation trend
Useful for response monitoring
ESR for inflammation
Less responsive than CRP
Serum lactate if systemic toxicity
Sepsis risk stratification
Microbiology
Blood cultures x2 if febrile or systemic signs
Higher yield in bacteremic presentations
HIV testing if risk factors
Broader pathogen spectrum
NAAT for gonorrhea and chlamydia if STI risk
Extra genital sites as indicated
Baseline safety labs
Creatinine and electrolytes for antibiotic dosing
Renal dosing planning
Liver enzymes if prolonged therapy anticipated
Antibiotic toxicity monitoring
Synovial fluid studies
Core synovial panel
Gross appearance
Purulent fluid high concern
Cell count with differential
WBC threshold patterns
Synovial WBC often > 50,000 cells/µL in nongonococcal infection
Lower counts possible with immunosuppression or early infection
Gram stain
Limited sensitivity
Aerobic culture
Definitive diagnosis
Anaerobic culture for bite or polymicrobial risk
Consider where appropriate
Crystal analysis
Monosodium urate and CPP crystals
Additional synovial tests by scenario
NAAT for N gonorrhoeae when available
Consider with suspected disseminated infection
AFB smear and culture
Chronic symptoms or TB risk
Fungal culture
Immunocompromised or endemic exposures
Diagnostic Tests
Scoring Systems
Pediatric septic hip probability tools
Kocher criteria
Fever
Non weight bearing
ESR elevation
Serum WBC elevation
Modified Kocher
CRP elevation as additional factor
Use limitations
Not definitive
Lower accuracy in the era of Kingella kingae and changing epidemiology
MRI
MRI indications
Suspected adjacent osteomyelitis
Persistent pain or systemic illness despite aspiration
Deep joint evaluation
Hip or sacroiliac infection concern
Occult abscess
Poor clinical response
MRI considerations
Need for sedation in pediatrics
Timing impact on source control
Contrast use
Abscess delineation
Interpretation pearls
Synovial enhancement and marrow edema for osteomyelitis
CT
CT roles
Image guided aspiration for deep joints
Hip or sacroiliac access
Alternative when MRI unavailable
Lower soft tissue detail than MRI
CT considerations
Contrast
Abscess detection
Radiation
Pediatrics minimization
Ultrasound
Ultrasound roles
Effusion detection
High utility for hip
Guidance for arthrocentesis
Improved yield in small effusions
POCUS integration
Effusion confirmation at bedside to expedite aspiration
Ultrasound limitations
Cannot exclude infection without aspiration
Effusion nonspecific
Disposition
Level of care
Admission indications
Suspected or confirmed septic arthritis
IV antibiotics and drainage planning
Systemic toxicity or sepsis
Monitoring and hemodynamic support
Hip, shoulder, sternoclavicular, or sacroiliac involvement
Higher complication risk
Prosthetic joint involvement
Multidisciplinary management
ICU indications
Vasopressor requirement
Septic shock
Respiratory failure
Advanced organ support
Transfer indications
Need for orthopedic surgery not available locally
Time sensitive source control
Discharge considerations
Discharge rare scenarios
Low suspicion after aspiration and alternative diagnosis confirmed
Reliable follow up within 24-48 hours
Confirmed gonococcal arthritis clinically stable
Outpatient parenteral therapy only with infectious diseases plan and close follow up
Treatment
Analgesia and supportive care
Symptom control
Acetaminophen PO 1,000 mg q6h PRN
Maximum 4,000 mg per day
Ibuprofen PO 400-600 mg q6-8h PRN
Avoid in CKD or GI bleed risk
Hydromorphone IV 0.2-0.5 mg q10-15 min PRN severe pain
Respiratory monitoring
Sepsis supportive care
IV crystalloids
Reassessment after each bolus
Norepinephrine infusion
Titrate to MAP at least 65 mmHg
Source control
Joint drainage strategy
Repeated needle aspiration
Suitable for accessible joints with improving clinical course
Arthroscopic irrigation and debridement
Common for knee and shoulder
Open arthrotomy
Hip infection or failure of less invasive drainage
Drainage timing
Same day source control when high suspicion or confirmed
Empiric antibiotics
Antibiotic timing
If clinically stable, then aspiration before antibiotics
Higher synovial culture yield
If sepsis or shock, then antibiotics immediately
Aspiration as soon as feasible after antibiotics
Native joint adult empiric
MRSA and MSSA coverage
Vancomycin IV 15-20 mg/kg q8-12h
Target AUC 400-600 when available
Gram negative coverage for older adults or immunocompromised
Ceftriaxone IV 2 g q24h
Higher dose for severe infection
Pseudomonas risk
Cefepime IV 2 g q8-12h
Renal dosing adjustment
Severe beta lactam allergy option
Aztreonam IV 2 g q8h
Add vancomycin for gram positive coverage
Suspected disseminated gonococcal infection
Ceftriaxone IV 1 g q24h
Add doxycycline PO 100 mg q12h for 7 days if chlamydia not excluded
Partner notification and treatment plan
Public health coordination
Bite or polymicrobial risk
Ampicillin sulbactam IV 3 g q6h
Broad gram positive and anaerobic coverage
Immunocompromised or atypical pathogen concern
Infectious diseases consultation early
Broaden coverage based on exposures and risk
Targeted antibiotics and duration
De escalation strategy
Narrow to culture and susceptibility results
Avoid unnecessary broad spectrum exposure
If cultures negative but high suspicion, then treat based on clinical course and synovial profile
Consider repeat aspiration or operative sampling
Duration framework
Typical total duration 2-4 weeks for native joint bacterial infection
Longer courses for delayed source control or osteomyelitis
IV to oral transition
Clinical improvement and downtrending CRP
Reliable oral agent with good bioavailability
Special Populations
Pregnancy
Pregnancy considerations
Maternal sepsis risk
Early obstetric consultation for systemic illness
Antibiotic safety
Ceftriaxone generally compatible with pregnancy
Avoid doxycycline in pregnancy
Imaging selection
Ultrasound preferred for effusion evaluation
MRI without gadolinium when needed
Geriatric
Older adult considerations
Atypical presentation
Less fever and less leukocytosis
Higher bacteremia risk
Blood cultures priority
Renal dosing
Vancomycin and cefepime adjustments
Functional baseline
Mobility and fall risk planning during admission
Pediatrics
Pediatric considerations
Hip septic arthritis as emergency
Early orthopedics involvement
Weight based dosing
Vancomycin IV 15 mg/kg q6h to q8h based on age and renal function
Kingella kingae consideration in toddlers
Lower fever and lower synovial WBC possible
Imaging selection
Ultrasound for hip effusion
MRI for osteomyelitis concern
Background
Epidemiology
Disease frequency
Most often monoarticular
Knee most common large joint in adults
Higher risk groups
Older adults
Rheumatoid arthritis
Prosthetic joints
Common pathogens
Staphylococcus aureus most common overall
MRSA prevalence varies by region and risk factors
Streptococci
Common in older adults
Gram negative bacilli
Higher in elderly and immunocompromised
Neisseria gonorrhoeae
Consider in sexually active adolescents and young adults
Pathophysiology
Infection routes
Hematogenous seeding
Bacteremia as common source
Direct inoculation
Injection or trauma
Contiguous spread
Cellulitis or osteomyelitis adjacent
Joint damage mechanisms
Neutrophil driven inflammation
Protease mediated cartilage destruction
Increased intraarticular pressure
Reduced perfusion and necrosis risk
Delayed drainage
Higher risk of permanent dysfunction
Therapeutic Considerations
Treatment pillars
Prompt drainage
Source control reduces bacterial load and pressure
Early effective antibiotics
Empiric coverage guided by gram stain and risk profile
Early mobilization after acute control
Prevent stiffness and loss of function
Monitoring response
Pain and range of motion improvement
Expected within 24-72 hours with adequate therapy
CRP downtrend
Useful for tracking
Repeat aspiration or operative management if poor response
Persistent fever or rising inflammatory markers
Patient Discharge Instructions
copy discharge instructions
Discharge plan overview
Diagnosis summary and uncertainty statement when applicable
Pending cultures and next steps
Medication instructions
Antibiotic schedule if prescribed
Activity guidance
Joint rest initially then gradual range of motion as advised
Return to ED now
Fever or rigors
Worsening systemic symptoms
Increasing joint pain or swelling
Reduced ability to move joint
New redness spreading around joint
Cellulitis progression
Weakness or numbness distal to joint
Neurovascular concern
Vomiting or inability to take medications
Dehydration risk
Follow up
Orthopedics and infectious diseases follow up as arranged
Appointment within 24-72 hours if outpatient plan
Primary care follow up
Risk factor management and prevention
References
Clinical guidelines and evidence sources
Guideline sources
Infectious Diseases Society recommendations for native joint septic arthritis management
Culture guided therapy and source control emphasis
American Academy of Orthopaedic Surgeons resources on septic arthritis and joint drainage
Operative vs aspiration decision frameworks
Evidence based reviews
Systematic reviews on synovial WBC thresholds and diagnostic accuracy
Synovial culture as gold standard
Literature on pediatric septic hip prediction rules
Kocher and modified Kocher performance limitations
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.